Research has shown that after receiving IORT-DT, the average level of tumour marker AFP in EG patients decreased by 16.2 ng/mL, nearly twice as high as the 8.6 ng/mL in CG (P<0.05). The gene discussed is AFP; the disease is neoplasm.